Clustering of silent cardiovascular risk factors in apparently healthy Hispanics

I S Hoffmann1, L X Cubeddu

  • 1Center for the Detection and Treatment of Silent Cardiovascular and Metabolic Risk Factors, Central University of Venezuela, Caracas, Venezuela. hoffmani@camelot.rect.ucv.ve

Insights

Many apparently healthy Hispanics have multiple silent cardiovascular risk factors, increasing their risk for heart disease and type 2 diabetes. Early screening and intervention are crucial for prevention.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Endocrinology

Background:

  • Ischaemic heart disease is a major cause of mortality.
  • Cardiovascular disease risk factors often develop silently.
  • Early detection and intervention are vital for prevention.

Purpose of the Study:

  • To assess the prevalence of cardiovascular risk factors in apparently healthy Hispanic adults.
  • To identify the extent of risk factor clustering.
  • To evaluate the presence of cardiovascular dysmetabolic syndrome.

Main Methods:

  • A screening program was implemented for apparently healthy individuals.
  • Data from the first 153 participants were analyzed.
  • Prevalence of modifiable risk factors including BMI, hypertension, and metabolic markers was recorded.

Main Results:

  • High prevalence of modifiable risk factors: overweight (33%), obesity (45%), sedentarism (84%), hypertension (15%), hyperinsulinaemia (50%), glucose intolerance (14%), type 2 diabetes (5%), hypercholesterolaemia (50%), hypertriglyceridaemia (28%), salt sensitivity (25%).
  • 59% of subjects had three or more risk factors; obesity was linked to greater clustering.
  • Cardiovascular dysmetabolic syndrome was present in 72% of obese individuals.

Conclusions:

  • Apparently healthy Hispanics exhibit a high prevalence of cardiovascular risk factors.
  • These individuals are at increased risk for cardiovascular disease and type 2 diabetes mellitus.
  • Implementing early detection and correction of modifiable risk factors is essential for prevention.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...